Gemcitabine, Paclitaxel, Ifosfamide, and Cisplatin in Treating Patients With Progressive or Relapsed Metastatic Germ Cell Tumors
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Cisplatin
Related studies linked through entity extraction aliases.
Dexrazoxane and Cisplatin in Treating Patients With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Combination Chemotherapy and Autologous Peripheral Stem Cell Transplant in Treating Patients With Stage III, Stage IV, or Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Randomized Trial Between Weekly and 5 Day 3 Weekly Cisplatin for Cervical Cancer
- Status
- UNKNOWN
- Phase
- PHASE3
A Study of Bevacizumab in Combination With Capecitabine and Cisplatin as First-line Therapy in Patients With Advanced Gastric Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Topotecan, Cisplatin and Bevacizumab for Recurrent/Persistent Cervical Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Radiotherapy Plus Panitumumab Compared to Chemoradiotherapy With Unresected, Locally Advanced Squamous Cell Carcinoma of the Head and Neck
- Status
- COMPLETED
- Phase
- PHASE2
Feasibility Study of CDDP + CPT-11 + PSK for Extensive-Stage Disease (ED) Small Cell Lung Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
R-(-)-Gossypol Acetic Acid, Cisplatin, and Etoposide in Treating Patients With Advanced Solid Tumors or Extensive Stage Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Chemotherapy Followed by Surgery, Chemotherapy, and Radiation Therapy in Treating Patients With Locally Advanced Head And Neck Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Fluorouracil, Cisplatin, Cetuximab, and Radiation Therapy in Treating Patients With Esophageal Cancer That Can Be Removed by Surgery
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Pemetrexed, Cisplatin, and Vitamin B12 in Treating Patients With Mesothelioma of the Chest That Cannot Be Removed by Surgery
- Status
- COMPLETED
- Phase
- PHASE2
Study for Participants With Advanced, Not Amenable to Surgery, or Metastatic Lung Cancer Comparing Treatment With Pemetrexed + Cisplatin + Enzastaurin Versus Pemetrexed + Cisplatin + Placebo
- Status
- TERMINATED
- Phase
- PHASE2
A Phase I/II Study to Determine the Maximum Tolerated Dose (MTD) and Safety of CC-4047 (Pomalidomide) Administered in Conjunction With Cisplatin and Etoposide
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Inoperable Non-Squamous NSCLC Stage III/IV: A Randomised Phase II Study With Bevacizumab Plus Erlotinib Or Gemcitabine/Cisplatin Plus Bevacizumab
- Status
- COMPLETED
- Phase
- PHASE2
Trial of Paclitaxel, Gemcitabine and Cisplatin in Patients With Relapsing Germ Cell Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Surgery, Gemcitabine, Cisplatin, and Radiation Therapy in Treating Patients With Stage II or Stage III Non-Small Cell Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Taxotere/Temodar/Cisplatin Study in Melanoma Patients
- Status
- COMPLETED
- Phase
- PHASE1
CAPPA-2: Cisplatin Added to Gemcitabine in Poor Performance Advanced NSCLC Patients
- Status
- TERMINATED
- Phase
- PHASE3
STAD-1 Small Cell Lung Cancer Toxicity Adjusted Dosing Study
- Status
- UNKNOWN
- Phase
- PHASE3